GE HealthCare, following its acquisition of MIM Software, a global leader in medical imaging analysis and AI solutions, proudly announces an expanded collaboration with Elekta, a precision radiation oncology leader. This partnership aims to innovate software solutions, enhancing clinician workflows, throughput, and patient experiences while enabling more precise treatments.
Radiation therapy (RT) plays a crucial role in cancer treatment, yet delays in treatment initiation persist due to interoperability issues and lack of automation. The collaboration seeks to address these challenges by integrating MIM Software’s solutions with Elekta’s treatment planning software, facilitating advanced oncology treatment planning globally.
Andy Nelson, CEO of MIM Software at GE HealthCare, highlights their commitment to streamlining clinical workflows and reducing treatment delays. The collaboration will leverage Elekta’s dose planning capabilities and MIM Software’s physician-preferred tools to enhance automation, adaptive therapy planning, and accuracy.
Maurits Wolleswinkel, Elekta’s President Linac and Software Solutions, emphasizes the significance of this collaboration for radiation therapy clinics and patients. By combining strengths, the partnership aims to deliver improved automation, adaptive therapy planning, and vendor-agnostic solutions globally.
This announcement complements GE HealthCare and Elekta’s existing global collaboration agreement, providing comprehensive imaging and treatment solutions for cancer patients requiring radiation therapy.
Ben Newton, GM of Oncology at GE HealthCare, underscores their commitment to meeting customer needs through collaborations and innovative solutions. The collaboration between GE HealthCare and MIM Software is a testament to their dedication to advancing cancer care.
GE HealthCare’s oncology solutions, including Intelligent RT (iRT), Maestro, and Discovery RT, powered by AI, aim to optimize cancer care pathways, from early detection to assessment.